Ranata Therapeutics

Ranata Therapeutics is an early-stage company that wants to build biologic drugs, antibodies or bispecifics, against the features that make one patient's cancer cells unique. Its site describes the idea as medicines inspired by your biology, for you. It is part of the Even One Ventures portfolio, a group of companies started to make scientific advances reach patients faster.

What it is working on

Antibodies are proteins that bind to a specific target. Bispecifics bind two targets at once. Ranata's site says it is improving these binder-based biologics to better target a tumor, starting from what is distinctive about that person's cancer cells rather than a target shared across many patients.

Where it stands

This is early. As of October 24, 2026, the site does not list a clinical trial, a price, eligibility rules or a date when patients could receive a treatment. I would treat it as a company to follow and ask questions of, not a treatment you can sign up for today.

How to start

The site has an "Explore your options" section that invites you to email the company. Bring a short summary of your diagnosis, treatment history and any tumor testing reports if you reach out.

How it fits

Like Echo Immune and Serova, Ranata is working on treatment built around one patient's tumor. Those two make personalized vaccines; Ranata is working on antibodies. Approaches like this depend on detailed information about your tumor, so Tumor testing is a good place to start. Clinical trials and Personalized cancer vaccines: what to ask cover questions that apply here too.

Questions I would ask

1. Is anything open to patients now, such as a study or an expanded access path?
2. What tumor testing would you need to find a target in my cancer?
3. How would my oncologist be involved?
4. How long would it take to go from my tumor data to a treatment?
5. What would it cost, and who would pay?

Contacts

• Website: ranatatx.com
• Email: info@ranatatx.com